| DATE | HS_CODE | Product Description | Trademark | Country | Net Weight | Statistical Cost | Place | Shipper Name | Consignee Name |
|---|
| 2017-09-02 | 3002109900 | MEDICINES (recombinant monoclonal antibodies) Packaging - syringes (not bottle) | CILAG AG | *** | 19.5 | 26097,6 | *** | ***** | ***** |
| 2017-09-05 | 3002200009 | LEK. PREPARATION FOR MEDICAL APPLICATIONS Pneumovax 23 (PNEUMOCOCCAL VACCINES, polyvalent), (vaccines for the prevention of pneumococcal infections) SOLUTION B / M and percutaneous administration, one dose (0.5 ml) (SYRINGE) X 1 (cardboard pack) (complete with | Pneumovax | *** | 1225.98 | 1066275,08 | MOSCOW | ***** | ***** |
| 2017-09-07 | 3002150000 | IMMUNOLOGICAL retail products (VED 2H) GENFAKSON (interferon beta-1a) solution for subcutaneous injection MLN.ME 12 (44 mcg) (syringe) of 0.5 ml (44 mcg) X 3 (paper cartons) - 25200 UE. SERIES IN117B valid until 07.2019, SERIES IN118B | GENFAKSON | *** | 1023.37 | 3687726,09 | MOSCOW | ***** | ***** |
| 2017-09-08 | 3002150000 | LEK.SR-VA, SOD. Immunological products, RASF. The unit dosage form and packaging for retail sale (NOT FOR VETERINARY) Orensakh (abatacept) R-P for subcutaneous administration of 125 mg / ml (C automatic retractable SYRINGE NEEDLE) 1.007 ML | Ourense | *** | 278.9 | 1291773,45 | MOSCOW | ***** | ***** |
| 2017-09-11 | 3002150000 | LEK.PREPARAT for honey. APPLICATIONS "IN BULK" NOT for retail sale: Humira (adalimumab) [solution for subcutaneous injection, 40mg / 0.8ML (SYRINGE) 0.8ML X1 + (NAPKIN ALCOHOL) X1] X1 (Blister) - 10000 conveying packs (1 pack contains 2 | Humira | *** | 763 | 6494597,92 | MOSCOW | ***** | ***** |
| 2017-09-11 | 3002150000 | IMMUNOLOGICAL retail products (VED 2H) GENFAKSON (interferon beta-1a) solution for subcutaneous injection MLN.ME 12 (44 mcg) (syringe) of 0.5 ml (44 mcg) X 3 (paper cartons) - 20464UP. SERIES IN119B, IN120B valid until 08.2019 The dash | GENFAKSON | *** | 831.04 | 3012642,06 | MOSCOW | ***** | ***** |
| 2017-09-12 | 3002109100 | Abatacept (BMS-188667, Orensakh) solution for subcutaneous injection of 125 mg / ml in 1 ml syringe - 128 syringe 32 4 BOX FOR SYRINGE SERIES - 4H68259, SHELF LIFE - 30.06.2016. | : BRISTOL-MYERS SQUIBB HOLDINGS PHARMA, LTD | UNITED STATES | 15.38 | 125836,86 | JOHN F KENNADI | ***** | ***** |
| 2017-09-13 | 3002109509 | Drugs based on monoclonal antibodies Packaging - syringes (not bottle) | JANSSEN PHARMACEUTICA COMPANIES OF JOHNSON & JOHNSON | *** | 16.15 | 599487,52 | *** | ***** | ***** |
| 2017-09-15 | 3002109900 | Medications SAR236553, solution for subcutaneous injection, not in bottles, not for sale for clinical research, in the training and medical kit, syringe RUCHKKAH volume of 1 ml | SANOFI AVENTIS | UNITED STATES | 154.5 | 429829,05 | MOSCOW | ***** | ***** |
| 2017-09-21 | 3002150000 | IMMUNOLOGICAL retail products (VED 2H) GENFAKSON (interferon beta-1a) solution for subcutaneous injection MLN.ME 12 (44 mcg) (syringe) of 0.5 ml (44 mcg) X 3 (paper cartons) - 26342 UE. SERIES IN123B, IN124B, IN125B valid until 08.2019 | GENFAKSON | *** | 1069.75 | 3802435,46 | MOSCOW | ***** | ***** |